Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Commissioner Calendar: Crawford Confirmed On April Fool's Day?

This article was originally published in The Pink Sheet Daily

Executive Summary

Crawford jokes at U.S. Pharmacopeia meeting that his confirmation process appears to revolve around holidays, including a confirmation hearing scheduled for St. Patrick's Day. Crawford's humor suggests he may be anticipating a smooth confirmation process.

You may also be interested in...



FDA Commissioner Confirmation Under Further Pressure From House Subcommittee

House Appropriations/Agriculture Subcommittee amends fiscal year 2006 appropriations bill to withhold 5% of funds for FDA's central office until the commissioner testifies on the agency's budget. The amended bill report says the Administration is preventing Acting Commissioner Crawford from testifying.

FDA Commissioner Confirmation Under Further Pressure From House Subcommittee

House Appropriations/Agriculture Subcommittee amends fiscal year 2006 appropriations bill to withhold 5% of funds for FDA's central office until the commissioner testifies on the agency's budget. The amended bill report says the Administration is preventing Acting Commissioner Crawford from testifying.

Commissioner Nominee Crawford Must Answer "Tough Questions" – Grassley

The Senate Health Committee schedules Crawford's confirmation hearing for March 17. Finance Committee Chairman Grassley indicates Crawford has "heart" for the post, but he may lack the management ability.

Related Content

Topics

UsernamePublicRestriction

Register

LL1126230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel